THYROCARE558.00

Thyrocare Technologies Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersLALPATHLABMETROPOLISVIJAYASUPRIYAVIYASHSTARSPARCYATHARTHMcap ₹8,882 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations571.9687.4829.0876.0
Other Income9.414.817.016.5
Total Income581.3702.2846.0892.5
Expenses
+ Cost of Materials Consumed164.5188.3218.7225.2
+ Purchases of Stock-in-Trade2.52.01.11.1
+ Changes in Inventories-0.30.8-0.2-0.1
+ Employee Benefit Expense107.9126.8138.1144.7
+ Finance Costs4.23.12.83.4
+ Depreciation & Amortisation47.055.358.659.7
+ Other Expenses159.9179.1209.4223.7
Total Expenses485.7555.3628.4657.5
EBITDA137.4190.4262.0281.5
EBIT90.4135.1203.5221.9
Profit
PBT before Exceptional Items95.6146.9217.7235.0
+ Exceptional Items0.00.0-6.2-6.2
Pretax Income95.6146.9211.5228.8
+ Current Tax30.147.857.361.5
+ Deferred Tax-3.66.9-7.3-6.7
Tax Expense26.554.750.054.8
+ Share of Associates & JVs0.4-1.41.41.9
Net Income69.590.8162.9175.9
+ Net Income — Continuing Ops69.192.2161.5174.0
+ Other Comprehensive Income0.3-0.80.41.0
Total Comprehensive Income69.890.0163.2176.9
Net Income to Common70.891.5163.1176.3
Minority Interest-1.3-0.8-0.2-0.4
Per Share
Basic EPS13.4217.1310.2717.09
Diluted EPS13.4017.0810.2417.04
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.80.41.0
+ Items NOT to be Reclassified to P&L0.51.2
+ Tax on Items NOT to be Reclassified1.00.10.2
+ Tax on Items NOT to be Reclassified — alt tag-0.4
+ Tax on Items to be Reclassified-0.3
+ Tax on Items to be Reclassified — alt tag0.1
Comprehensive Income — Owners of Parent71.190.7163.4177.3
Comprehensive Income — Non-controlling Interests-1.3-0.8-0.2-0.4
Per Share — as-filed variants
Basic EPS — Continuing Operations13.4217.1310.2717.09
Diluted EPS — Continuing Operations13.4017.0810.2417.04
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit405.2496.3609.5649.9
Gross Margin %70.8572.2073.5274.19
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)95.6146.9217.7235.0
− Exceptional Items (reconciliation)0.00.0-6.2-6.2
Net Income Adj (tax-effected)69.590.8167.6180.6
EPS Adj13.4217.1310.5717.55
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Filed Debt Equity0.000.00
Paid Up Equity Capital53.053.0159.2159.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.